mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.1 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.081 |
0.2 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.4 |
0.2 |